As of May 3, 2021, a total of around 62.7 thousand cartons of coronavirus disease (COVID-19) vaccination developed by Pfizer Inc. and BioNTech SE were prepared to be supplied to municipalities in Japan by July 4, 2021. Those cartons of vaccination were designed to be primarily administered to citizens aged 65 and older. The government planned to complete the administration of Pfizer-BioNTech COVID-19 vaccination for the elderly by the end of July 2021.
The supply of COVID-19 vaccination in Japan has begun on February 17, 2021, mainly for health professionals. On April 12, 2021, the government started the vaccine administration for citizens aged 65 and older.
Planned supply number of coronavirus disease (COVID-19) vaccine for citizens developed by Pfizer-BioNTech in Japan as of May 3, 2021
(in cartons)
*The health ministry planned to also distribute syringes to administer six doses per one vial from May 10, 2021, and onward.
**The number of cartons was planned to be added depending on the demand from the municipalities from May 24, 2021, and onward.
A carton includes 195 vials, which equates to 975 doses (five doses per one vial) or 1,170 doses (six doses per one vial).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
MHLW (Japan). (May 3, 2021). Planned supply number of coronavirus disease (COVID-19) vaccine for citizens developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons) [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1238856/japan-supply-number-pfizer-coronavirus-19-vaccine-citizens/
MHLW (Japan). "Planned supply number of coronavirus disease (COVID-19) vaccine for citizens developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons)." Chart. May 3, 2021. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1238856/japan-supply-number-pfizer-coronavirus-19-vaccine-citizens/
MHLW (Japan). (2021). Planned supply number of coronavirus disease (COVID-19) vaccine for citizens developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons). Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1238856/japan-supply-number-pfizer-coronavirus-19-vaccine-citizens/
MHLW (Japan). "Planned Supply Number of Coronavirus Disease (Covid-19) Vaccine for Citizens Developed by Pfizer-biontech in Japan as of May 3, 2021 (in Cartons)." Statista, Statista Inc., 3 May 2021, https://www.statista.com/statistics/1238856/japan-supply-number-pfizer-coronavirus-19-vaccine-citizens/
MHLW (Japan), Planned supply number of coronavirus disease (COVID-19) vaccine for citizens developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons) Statista, https://www.statista.com/statistics/1238856/japan-supply-number-pfizer-coronavirus-19-vaccine-citizens/ (last visited December 22, 2024)
Planned supply number of coronavirus disease (COVID-19) vaccine for citizens developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons) [Graph], MHLW (Japan), May 3, 2021. [Online]. Available: https://www.statista.com/statistics/1238856/japan-supply-number-pfizer-coronavirus-19-vaccine-citizens/
